David Huang, chief medical officer of Motif Bio said: "We are delighted to welcome these three outstanding scientific leaders to our Clinical Advisory Board. Each of them brings specific expertise that will be invaluable as we develop and prepare to commercialise iclaprim for patients with serious and life-threatening infections."
Thomas Lodise is a Professor at Albany College of Pharmacy and Health Sciences, Albany, New York and an infectious diseases clinical pharmacy specialist at the Stratton VA Medical Center.
Thomas Holland is an Assistant Professor in the Department of Infectious Diseases at Duke University School of Medicine and Board certified in infectious disease.
William O'Riordan, is the founder and CEO of eStudy Sites, one of the pre-eminent network of clinical trial sites in the US He is certified with the American Board of Emergency Medicine and is the lead investigator at the Chula Vista Research Site in California.